TCL Archive Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change. September 30, 2005
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light November 26, 2014
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
